top of page
>
>
Immuno-oncology competitive intelligence
Client Problems
- A mid-size biotech company has an immuno-oncology therapy with a new MOA in clinical trials
- They want to determine the current and future landscape for immuno-oncology products, especially with unique MOAs
- Gain insights from competitors clinical trials and launches and create a differentiation strategy
What We Did
- Identified all the current players in the immuno-oncology space and stratified them their drug candidates according to MOA, lines of therapy, indications, mono vs combo therapies.
- Analyzed their clinical trials and determine the trial size, patient segmentation and biomarker strategy
- Determined the approvals and launches of the competitors products
- Created a differentiation strategy
Our Results And Insight
- Emerging immuno-oncology and new therapeutic MOA candidates clinical trials landscape
- Competitor approvals and anticipated launch timelines
- Summary of clinical trial deep dive
- Overview of differentiation strategy
See other case studies
Commercial Strategy case studies >
Oncology case studies >
Service Areas Details
Commercial Strategy (Competitive assessment)
Therapeutic Areas Details
Oncology (Solid Tumor, Immuno-oncology)
Featured Consultants
bottom of page